Literature DB >> 26476561

Impact of tumour invasion on seminal vesicles mobility in radiotherapy of prostate cancer.

Monica van der Burgt1, Laura Bergsma1, Jeroen de Vries2, Floris J Pos1, Robin Kalisvaart1, Wilma Heemsbergen1, Peter Remeijer1, Uulke A van der Heide3.   

Abstract

PURPOSE: Mobility of the seminal vesicles relative to the prostate challenges adequate dose coverage. The aim of this study was to assess the impact of tumour invasion on SV mobility. METHODS AND MATERIALS: Three groups of 30 prostate cancer patients with (1) no invasion on MR, (2) minimal invasion (<5mm), and (3) extensive invasion (>5mm) were studied. Translations and rotations of the SV were measured with CBCT and compared between the three groups.
RESULTS: In the extensive group the random SV translations were significantly lower in comparison with the no invasion group in the LR: 0.15 vs 0.16 cm (p=0.015), CC: 0.17 vs 0.23 cm (p=0.004) and AP direction: 0.19 vs 0.26 cm (p=0.002). Also the random SV rotation on the LR axis was significantly lower: 5.2 vs 6.3° (p=0.035). In comparison with the minimal invasion group the random SV translations were significantly lower in the extensive group in the CC: 0.17 vs 0.24 cm (p=0.001) and AP direction 0.19 vs 0.31 cm (p=0.007) and for the rotation on the LR axis: 5.2 vs 6.5° (p=0.043).
CONCLUSION: Increasing tumour invasion in the SV reduces the mobility of the SV, however the mobility remains considerable.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ART; Inter-fraction organ motion; Prostate radiotherapy; SV invasion

Mesh:

Year:  2015        PMID: 26476561     DOI: 10.1016/j.radonc.2015.09.031

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  3 in total

1.  Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption.

Authors:  Shyama U Tetar; Anna M E Bruynzeel; Lisa Verweij; Omar Bohoudi; Berend J Slotman; Tezontl Rosario; Miguel A Palacios; Frank J Lagerwaard
Journal:  Phys Imaging Radiat Oncol       Date:  2022-07-03

2.  Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control.

Authors:  Per Munck Af Rosenschold; Michael J Zelefsky; Aditya P Apte; Andrew Jackson; Jung Hun Oh; Elliot Shulman; Neil Desai; Margie Hunt; Pirus Ghadjar; Ellen Yorke; Joseph O Deasy
Journal:  Radiat Oncol       Date:  2018-04-12       Impact factor: 3.481

3.  Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysis.

Authors:  Flora Goupy; Stéphane Supiot; David Pasquier; Igor Latorzeff; Ulrike Schick; Erik Monpetit; Geoffrey Martinage; Chloé Hervé; Bernadette Le Proust; Joel Castelli; Renaud de Crevoisier
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.